A double-blind study of heteronium bromide and amobarbital in the management of gastrointestinal conditions associated with anxiety (Q51338438): Preview

A double-blind study of heteronium bromide and amobarbital in the management of gastrointestinal conditions associated with anxiety (Q51338438)
scientific article published in October 1968

Language:

Current Data About A double-blind study of heteronium bromide and amobarbital in the management of gastrointestinal conditions associated with anxiety

(P31)

(Q13442814)

(P248)
(P698)	4971465
(P813)	Tuesday, April 3, 2018
(P854)	http://europepmc.org/abstract/MED/4971465

(P304)

508-513

(P248)
(P698)	4971465
(P813)	Tuesday, April 3, 2018
(P854)	http://europepmc.org/abstract/MED/4971465

(P433)

(P248)
(P698)	4971465
(P813)	Tuesday, April 3, 2018
(P854)	http://europepmc.org/abstract/MED/4971465

(P478)

(P248)
(P698)	4971465
(P813)	Tuesday, April 3, 2018
(P854)	http://europepmc.org/abstract/MED/4971465

(P577)

Tuesday, October 1, 1968

(P248)
(P698)	4971465
(P813)	Tuesday, April 3, 2018
(P854)	http://europepmc.org/abstract/MED/4971465

(P1433)

(Q15752574)

(P248)
(P698)	4971465
(P813)	Tuesday, April 3, 2018
(P854)	http://europepmc.org/abstract/MED/4971465

(P1476)

"A double-blind study of heteronium bromide and amobarbital in the management of gastrointestinal conditions associated with anxiety" (language: en)

(P248)
(P698)	4971465
(P813)	Tuesday, April 3, 2018
(P854)	http://europepmc.org/abstract/MED/4971465

(P2093)

Kasich AM

(P1545)	1

(P248)
(P698)	4971465
(P813)	Tuesday, April 3, 2018
(P854)	http://europepmc.org/abstract/MED/4971465

other details

description	scientific article published in October 1968

External Links

(P698)	4971465